Search results
Medifast (MED) Tumbles More Than 40% in 3 Months: Here's Why
Zacks via Yahoo News· 1 month agoMedifast (MED) battles persistent customer acquisition challenges aggravated by macroeconomic...
Medifast's (MED) Transformation on Track Amid Macro Headwinds
Zacks via Yahoo News· 3 months agoMedifast (MED) adapts to shifting consumer behavior to maintain its relevance. However, it is facing...
Medifast (MED) Soars 5.9%: Is Further Upside Left in the Stock?
Zacks via Yahoo News· 4 months agoMedifast (MED) witnessed a jump in share price last session on above-average trading volume. The...
Medifast (MED) Q1 Earnings Miss Estimates, Revenues Fall Y/Y
Zacks via Yahoo News· 3 months agoMedifast's (MED) first-quarter results reflect challenges related to a decline in active earning...
Medifast (MED) Down More Than 20% in 3 Months on Cost Woes
Zacks via Yahoo News· 2 years agoMedifast (MED) has been seeing high SG&A expenses and escalated raw material costs. The company...
Medifast (MED) Poised on OPTAVIA ACTIVE Line Amid Cost Woes
Zacks via Yahoo News· 8 months agoMedifast (MED) is proactively positioning itself to tap into the increasing demand for weight loss...
Medifast (MED) Q2 Earnings and Revenues Surpass Estimates
Zacks via Yahoo News· 11 months agoMedifast (MED) delivered earnings and revenue surprises of 92.36% and 16.85%, respectively, for the...
Medifast (MED) is a Top Dividend Stock Right Now: Should You Buy?
Zacks via Yahoo News· 2 years agoDividends are one of the best benefits to being a shareholder, but finding a great dividend stock is...
Medifast (MED) Gains on OPTAVIA Lifestyle Solution Strength
Zacks via Yahoo News· 10 months agoMedifast's (MED) OPTAVIA program is a robust and adaptable solution focused on health and wellness....
Medifast (MED) Readies for Q2 Earnings: What's in the Cards?
Zacks via Yahoo News· 2 years agoMedifast's (MED) second-quarter 2022 results are likely to reflect gains from its OPTAVIA lifestyle...